Royal Hallamshire Hospital
Sheffield, South Yorkshire S10 2RX
1 studies enrolling now · 6 studies all time
What they study most
Alopecia, Alzheimer's Disease Dementia, Atopic Dermatitis, Crohn's Disease, Metastatic Breast Cancer, Mild Cognitive Impairment Due to Alzheimer's Disease, Non-muscle Invasive Bladder Cancer
Studies at this site
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer — Recruiting now
- A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
- Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) — Completed
- Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
- A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease — Completed
- Clinical Trial in Females With Female Pattern Hair Loss — Completed